You are cordially ​invited by your Bristol-Myers Squibb Representative Arsalan Fooladoi Mark.fooladi@bms.com
A Treatment Option for the Management of Patients with Intermediate or Poor-Risk, Previously Untreated Advanced Renal Cell Carinoma And Hepatocellular Carcinoma Previously Treated with Sorafenib
Tuesday, November 12, 2019
6:30pm-MST
Ranchers Club of New Mexico
1901 University Blvd NE
Albuquerque NM, 87102
505-889-8071
Program Faculty
Andrea Cannon, PharmD, BCOP, BCPS
Immuno-Oncology Clinician Liaison
Bristol-Myers Squibb
Meeting ID:
191112-BMS-50431
To RSVP:
Call 1-866-326-7600 during the hours of 8:30am to 5:00pm EST, and refer to meeting ID